Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study von Broeker, A, Wicha, S G, Dorn, C, Kratzer, A, Schleibinger, M, Kees, F, Heininger, A, Kees, M G, Häberle, H

Volltext

Significance of FAB subclassification of “acute myeloid leukemia, NOS” in the 2008 WHO classification: analysis of 5848 newly diagnosed patients von Walter, Roland B., Othus, Megan, Burnett, Alan K., Löwenberg, Bob, Kantarjian, Hagop M., Ossenkoppele, Gert J., Hills, Robert K., van Montfort, Kees G.M., Ravandi, Farhad, Evans, Anna, Pierce, Sherry R., Appelbaum, Frederick R., Estey, Elihu H.

Volltext

Increased aortic stiffness and blood pressure in non-classic Pompe disease von Wens, Stephan C. A., Kuperus, Esther, Mattace-Raso, Francesco U. S., Kruijshaar, Michelle E., Brusse, Esther, van Montfort, Kees C. A. G. M., de Boer, Marjan Scheltens, Sijbrands, Eric J. G., van der Ploeg, Ans T., van Doorn, Pieter A.

Volltext

Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients von Kees, Martin G., Weber, Susanne, Kees, Frieder, Horbach, Thomas

Volltext

Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric-Coated Mycophenolate Sodium in Healthy Volunteers von Kees, M. G., Steinke, T., Moritz, S., Rupprecht, K., Paulus, E. M., Kees, F., Bucher, M., Faerber, L.

Volltext

Screening for obstructive sleep apnea in treacher-collins syndrome von Plomp, Raul G., Joosten, Koen F. M., Wolvius, Eppo B., Hoeve, Hans L. J., Poublon, Rene M. L., van Montfort, Kees A. G. M., Bredero-Boelhouwer, Hansje H., Mathijssen, Irene M. J.

Volltext

The Development and Validation of a Decision-Analytic Model Representing the Full Disease Course of Acute Myeloid Leukemia von Leunis, Annemieke, Redekop, W. Ken, van Montfort, Kees A. G. M., Löwenberg, Bob, Uyl-de Groot, Carin A.

Volltext

Strategies to avoid antibiotic resistance von Kees, M G

Volltext

Pharmacokinetics of vancomycin during continuous infusion in ICU patients: 12AP1–2 von Kees, M G, Kees, F, Vögeler, S

Volltext

HDL and cardiovascular disease von Rader, Daniel J, Prof, Hovingh, G Kees, MD

Volltext

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial von Raal, Frederick J, Prof, Stein, Evan A, Prof, Dufour, Robert, MD, Turner, Traci, MD, Civeira, Fernando, MD, Burgess, Lesley, Prof, Langslet, Gisle, MD, Scott, Russell, Prof, Olsson, Anders G, Prof, Sullivan, David, MD, Hovingh, G Kees, MD, Cariou, Bertrand, MD, Gouni-Berthold, Ioanna, MD, Somaratne, Ransi, MD, Bridges, Ian, MSc, Scott, Rob, MD, Wasserman, Scott M, MD, Gaudet, Daniel, Prof

Volltext

Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial von Raal, Frederick J, Prof, Honarpour, Narimon, MD, Blom, Dirk J, MD, Hovingh, G Kees, MD, Xu, Feng, MS, Scott, Rob, MD, Wasserman, Scott M, MD, Stein, Evan A, Prof

Volltext

Via β-adrenoceptors, stimulation of extrasplenic sympathetic nerve fibers inhibits lipopolysaccharide-induced TNF secretion in perfused rat spleen von Kees, Martin G., Pongratz, Georg, Kees, Frieder, Schölmerich, Jürgen, Straub, Rainer H.

Volltext

Nasal sequelae of Treacher Collins syndrome von Plomp, Raul G, Mathijssen, Irene M.J, Moolenburgh, Sanne E, van Montfort, Kees A.G.M, van der Meulen, Jacques J.N.M, Poublon, René M.L

Volltext

Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia von van Wijk, Diederik F., MD, Sjouke, Barbara, MD, Figueroa, Amparo, MD, Emami, Hamed, MD, van der Valk, Fleur M., MD, MacNabb, Megan H., BA, Hemphill, Linda C., MD, Schulte, Dominik M., MD, PhD, Koopman, Marion G., MD, PhD, Lobatto, Mark E., MD, Verberne, Hein J., MD, PhD, Fayad, Zahi A., MD, PhD, Kastelein, John J.P., MD, PhD, Mulder, Willem J.M., PhD, Hovingh, G. Kees, MD, PhD, Tawakol, Ahmed, MD, Stroes, Erik S.G., MD, PhD

Volltext

Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study von Kastelein, John J P, Prof, Besseling, Joost, MD, Shah, Sukrut, PhD, Bergeron, Jean, MD, Langslet, Gisle, MD, Hovingh, G Kees, MD, Al-Saady, Naab, MD, Koeijvoets, Michiel, BSc, Hunter, John, MS, Johnson-Levonas, Amy O, PhD, Fable, Jennifer, PharmD, Sapre, Aditi, PhD, Mitchel, Yale, MD

Volltext

Population pharmacokinetics and pharmacodynamic evaluation of intravenous and enteral moxifloxacin in surgical intensive care unit patients von Kees, Martin Georg, Schaeftlein, André, Haeberle, Helene Anna, Kees, Frieder, Kloft, Charlotte, Heininger, Alexandra

Volltext

Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk Algorithms von Verbeek, Rutger, MD, Sandhu, Manjinder S., PhD, Hovingh, G. Kees, MD, PhD, Sjouke, Barbara, MD, Wareham, Nicholas J., MBBS, PhD, Zwinderman, Aeilko H., PhD, Kastelein, John J.P., MD, PhD, Khaw, Kay-Tee, MBBChir, Tsimikas, Sotirios, MD, Boekholdt, S. Matthijs, MD, PhD

Volltext

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study von Sjouke, Barbara, MD, Langslet, Gisle, MD, Ceska, Richard, Prof, Nicholls, Stephen J, Prof, Nissen, Steven E, Prof, Öhlander, Maria, MSc, Ladenson, Paul W, Prof, Olsson, Anders G, Prof, Hovingh, G Kees, MD, Kastelein, John J P, Prof

Volltext

Statin and the Risk of Renal-Related Serious Adverse Events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and Other Placebo-Controlled Trials von Bangalore, Sripal, MD, MHA, Fayyad, Rana, PhD, Hovingh, G. Kees, MD, Laskey, Rachel, PhD, Vogt, Liffert, MD, DeMicco, David A., PharmD, Waters, David D., MD

Volltext